When to include clinical study reports and regulatory documents in systematic reviews
JournalBMJ Evidence-Based Medicine
PublisherBMJ Publishing Group
MetadataShow full item record
AbstractReporting bias is a major threat to the validity and credibility of systematic reviews. This article outlines the rationale for accessing clinical study reports and other regulatory documents (regulatory data) as a means of addressing reporting bias and identifies factors that may help decide whether (or not) to include regulatory data in systematic reviews. The article also describes the origins and current state of regulatory data access and summarises a survey of current systematic reviewers' practices in considering regulatory data for inclusion in systematic reviews. How to access and extract regulatory data is not addressed. Organisations and other stakeholders such as Cochrane should encourage the use of data from clinical study reports as an important source of data in reviews of pharmaceutical interventions particularly when the intervention in question is of high importance and the risk of reporting bias is great. Copyright Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85054922091&doi=10.1136%2fbmjebm-2018-110963&partnerID=40&md5=55927ff61b941ad2d70b74d90f62a21e; http://hdl.handle.net/10713/9449
- The use of clinical study reports to enhance the quality of systematic reviews: a survey of systematic review authors.
- Authors: Hodkinson A, Dietz KC, Lefebvre C, Golder S, Jones M, Doshi P, Heneghan C, Jefferson T, Boutron I, Stewart L
- Issue date: 2018 Aug 8
- Towards greater understanding of implementation during systematic reviews of complex healthcare interventions: the framework for implementation transferability applicability reporting (FITAR).
- Authors: Baxter S, Johnson M, Chambers D, Sutton A, Goyder E, Booth A
- Issue date: 2019 Apr 18
- Risk of bias assessments for selective reporting were inadequate in the majority of Cochrane reviews.
- Authors: Saric F, Barcot O, Puljak L
- Issue date: 2019 Aug
- Consideration of health inequalities in systematic reviews: a mapping review of guidance.
- Authors: Maden M
- Issue date: 2016 Nov 28
- Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
- Authors: Manchikanti L, Datta S, Smith HS, Hirsch JA
- Issue date: 2009 Sep-Oct